SM

Sonika Madaan

Active Director Director DIN 09104743
DIN 09104743 First appointment Mar 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Sonika Madaan

Data last updated:

Sonika Madaan is a Director at Gementis Lifesciences Private Limited (since 2021). The company operates in Chemicals. Gementis Lifesciences Private Limited reported revenue of ₹4.77 Cr (FY 2025).

DIN 09104743
Primary Designation Director
Industry Chemicals
First Appointment 13 Mar 2021
Oldest Company Age 5 yrs
Largest company Gementis Lifesciences Private Limited · ₹4.77 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Mar 20212021₹4.77 Cr (FY 2025)Active

Board colleagues of Sonika Madaan

NameDINCompanyDesignation
Gaurav Madan10099293Gementis Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gementis Lifesciences Private Limited
Premium access

Shareholding and investment profile for Sonika Madaan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonika Madaan

Sonika Madaan currently holds 1 directorship: Gementis Lifesciences Private Limited (Director, since 13 Mar 2021, revenue ₹4.77 Cr (FY 2025)).

Sonika Madaan was first appointed on 13 Mar 2021 as Director at Gementis Lifesciences Private Limited.

The current boards of Sonika Madaan's companies include Gaurav Madan (Gementis Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available